The company considered several attractive sites in other countries, but chose Ireland due to its thriving biotechnology community, infrastructure to support biologics manufacturing and attractive business climate. Our new facilities in Cork will enhance our ability to deliver on Amgen's robust pipeline.

Fabrizio Bonanni